Therapy area: HIV | |||
Generic | Strength | Approval Status | |
Dolutegravir Tablets | 50mg | WHO/USFDA/NMPA | |
Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate Tablets | 50mg/300mg/300mg | WHO/USFD AIn process (NMPA） | |
Lamivudine and Zidovudine Tablets | 150mg/300mg | WHO/USFDA/NMPA | |
Ritonavir Tablets | 100mg | WHO/NMPA | |
Efavirenz Tablets | 50mg、200mg、600mg | WHO/NMPA | |
Atazanavir/Ritonavir Tablets | 300mg/100mg | WHO | |
Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate Tablets | 400mg/300mg/300mg | NMPA | |
Lamivudine and Tenofovir Disoproxil Fumarate Tablets | 300mg/300mg | NMPA | |
Emtricitabine and Tenofovir Alafenamide Fumarate Tablets | 200mg/25mg | NMPA | |
Nevrapine/Zidovudine/Lamivudine Tablets | 200mg/300mg/150mg | NMPA | |
Lopinavir and Ritonavir Tablets | 100mg/25mg 200mg/50mg | NMPA | |
Nevirapine Tablets | 200mg | NMPA | |
Zidovudine Tablets | 300mg | NMPA | |
Lamivudine Tablets | 150mg、300mg | NMPA | |
Emtricitabine and Tenofovir Disoproxil Fumarate Tablets | 200mg/300mg | NMPA WHO | |
Abacavir Sulfate Tablets | 300mg | NMPA | |
Tenofovir Alafenamide Fumarate/Emtricitabine/Dolutegravir Tablets | 25mg/200mg/50mg | In process (WHO) | |
Lamivudine and Dolutegravir Tablets | 300mg/50mg | NMPA | |
Tenofovir Alafenamide Fumarate/Lamiyudine/Dolutegravir Tablets | 25mg/300mg/50mg | In R&D | |
Therapy area: HBV | |||
Generic | Strength | Approval Status | |
Lamivudine Tablets | 100mg | NMPA | |
Tenofovir Alafenamide Fumarate Tablets | 25mg | NMPA | |
Tenofovir Disoproxil Fumarate Tablets | 300mg | NMPA | |
Therapy area: Bacterial infectio | |||
Generic | Strength | Approval Status | |
Linezolid Tablets | 600mg | NMPA | |
Linezolid and Glucose Injection | 100ml: Linezolid 0.2g Glucose 5g 300ml: Linezolid 0.6g Glucose 15g | NMPA | |
Tedizolid Phosphate Tablets | 200mg | NMPA | |
Levofloxacin Hvdrochloride Tablets | 100mg | NMPA | |
Levofloxacin Hydrochloride Capsules | 100mg | NMPA | |
Others | |||
Generic | Strength | Therapy area | Approval Status |
Molnupiravir Capsules | 200mg | COVID-19 | WHO |
Nirmatrelvir Tablets/Ritonavir Tablets (CO-PACKAGED) | 150mg/100mg | COVID-19 | WHO |
Edoxaban Tosilate Tablets | 30mg, 60mg | Thrombosis | NMPA |
Avatrombopag Maleate Tablets | 20mg | Thrombocytopenia | NMPA |
Roxadustat Capsules | 50mg | Renal Anemia | NMPA |
Letermovir Tablets | 240mg | Cytomegalovirus infection | in process (NMPA) |
